Elevations of cardiac troponin I associated with myocarditis: Experimental and clinical correlates

Stacy C. Smith, Jack H. Ladenson, Jay W. Mason, Allan S Jaffe

Research output: Contribution to journalArticle

381 Citations (Scopus)

Abstract

Background: Endomyocardial biopsy is currently the standard method used to diagnose myocarditis. However, it is invasive and has a low diagnostic yield. Because the histological diagnosis of myocarditis requires the presence of myocyte injury, we sought to determine whether measurement of cardiac troponin I (cTnI), which is a serum marker with high sensitivity and specificity for cardiac myocyte injury, could aid in the diagnosis of myocarditis. Methods and Results: To validate this approach, cTnI values were first measured in mice with autoimmune myocarditis. cTnI values were elevated in 24 of 26 mice with myocarditis but were not elevated in any of the control animals (P<.001). Next, cTnI values were measured in the sera from 88 patients referred to the Myocarditis Treatment Trial were compared with creatine kinase-MB (CK-MB) values measured in the same patients. cTnI values were elevated in 18 (34%) of 53 patients with myocarditis and in only 4 (11%) of 35 patients without myocarditis (P=.01). In contrast, CK-MB values were elevated in only 3 (5.7%) of 53 patients with myocarditis and 0 of 35 patients without myocarditis (P=.27). Thus, elevations of cTnI occurred more frequently than did elevations of CK-MB in patients with biopsy-proven myocarditis (P=.001). Importantly, elevations of cTnI in patients with myocarditis were significantly correlated with ≤1 month duration of heart failure symptoms (P=.02), suggesting that the majority of myocyte necrosis occurs early, and thus the window for diagnosis and treatment may be relatively brief. Conclusions: cTnI was superior to CK-MB for detection of myocyte injury in myocarditis, and cTnI elevations were substantially more commons in the first month after the onset of heart failure symptoms.

Original languageEnglish (US)
Pages (from-to)163-168
Number of pages6
JournalCirculation
Volume95
Issue number1
StatePublished - 1997
Externally publishedYes

Fingerprint

Troponin I
Myocarditis
MB Form Creatine Kinase
Muscle Cells
Wounds and Injuries
Heart Failure
Biopsy
Cardiac Myocytes
Necrosis

Keywords

  • cardiac troponin I
  • creatine kinase
  • diagnosis
  • myocarditis

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Elevations of cardiac troponin I associated with myocarditis : Experimental and clinical correlates. / Smith, Stacy C.; Ladenson, Jack H.; Mason, Jay W.; Jaffe, Allan S.

In: Circulation, Vol. 95, No. 1, 1997, p. 163-168.

Research output: Contribution to journalArticle

Smith, Stacy C. ; Ladenson, Jack H. ; Mason, Jay W. ; Jaffe, Allan S. / Elevations of cardiac troponin I associated with myocarditis : Experimental and clinical correlates. In: Circulation. 1997 ; Vol. 95, No. 1. pp. 163-168.
@article{f6f5339ac1cd44609f42972bda9a1152,
title = "Elevations of cardiac troponin I associated with myocarditis: Experimental and clinical correlates",
abstract = "Background: Endomyocardial biopsy is currently the standard method used to diagnose myocarditis. However, it is invasive and has a low diagnostic yield. Because the histological diagnosis of myocarditis requires the presence of myocyte injury, we sought to determine whether measurement of cardiac troponin I (cTnI), which is a serum marker with high sensitivity and specificity for cardiac myocyte injury, could aid in the diagnosis of myocarditis. Methods and Results: To validate this approach, cTnI values were first measured in mice with autoimmune myocarditis. cTnI values were elevated in 24 of 26 mice with myocarditis but were not elevated in any of the control animals (P<.001). Next, cTnI values were measured in the sera from 88 patients referred to the Myocarditis Treatment Trial were compared with creatine kinase-MB (CK-MB) values measured in the same patients. cTnI values were elevated in 18 (34{\%}) of 53 patients with myocarditis and in only 4 (11{\%}) of 35 patients without myocarditis (P=.01). In contrast, CK-MB values were elevated in only 3 (5.7{\%}) of 53 patients with myocarditis and 0 of 35 patients without myocarditis (P=.27). Thus, elevations of cTnI occurred more frequently than did elevations of CK-MB in patients with biopsy-proven myocarditis (P=.001). Importantly, elevations of cTnI in patients with myocarditis were significantly correlated with ≤1 month duration of heart failure symptoms (P=.02), suggesting that the majority of myocyte necrosis occurs early, and thus the window for diagnosis and treatment may be relatively brief. Conclusions: cTnI was superior to CK-MB for detection of myocyte injury in myocarditis, and cTnI elevations were substantially more commons in the first month after the onset of heart failure symptoms.",
keywords = "cardiac troponin I, creatine kinase, diagnosis, myocarditis",
author = "Smith, {Stacy C.} and Ladenson, {Jack H.} and Mason, {Jay W.} and Jaffe, {Allan S}",
year = "1997",
language = "English (US)",
volume = "95",
pages = "163--168",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Elevations of cardiac troponin I associated with myocarditis

T2 - Experimental and clinical correlates

AU - Smith, Stacy C.

AU - Ladenson, Jack H.

AU - Mason, Jay W.

AU - Jaffe, Allan S

PY - 1997

Y1 - 1997

N2 - Background: Endomyocardial biopsy is currently the standard method used to diagnose myocarditis. However, it is invasive and has a low diagnostic yield. Because the histological diagnosis of myocarditis requires the presence of myocyte injury, we sought to determine whether measurement of cardiac troponin I (cTnI), which is a serum marker with high sensitivity and specificity for cardiac myocyte injury, could aid in the diagnosis of myocarditis. Methods and Results: To validate this approach, cTnI values were first measured in mice with autoimmune myocarditis. cTnI values were elevated in 24 of 26 mice with myocarditis but were not elevated in any of the control animals (P<.001). Next, cTnI values were measured in the sera from 88 patients referred to the Myocarditis Treatment Trial were compared with creatine kinase-MB (CK-MB) values measured in the same patients. cTnI values were elevated in 18 (34%) of 53 patients with myocarditis and in only 4 (11%) of 35 patients without myocarditis (P=.01). In contrast, CK-MB values were elevated in only 3 (5.7%) of 53 patients with myocarditis and 0 of 35 patients without myocarditis (P=.27). Thus, elevations of cTnI occurred more frequently than did elevations of CK-MB in patients with biopsy-proven myocarditis (P=.001). Importantly, elevations of cTnI in patients with myocarditis were significantly correlated with ≤1 month duration of heart failure symptoms (P=.02), suggesting that the majority of myocyte necrosis occurs early, and thus the window for diagnosis and treatment may be relatively brief. Conclusions: cTnI was superior to CK-MB for detection of myocyte injury in myocarditis, and cTnI elevations were substantially more commons in the first month after the onset of heart failure symptoms.

AB - Background: Endomyocardial biopsy is currently the standard method used to diagnose myocarditis. However, it is invasive and has a low diagnostic yield. Because the histological diagnosis of myocarditis requires the presence of myocyte injury, we sought to determine whether measurement of cardiac troponin I (cTnI), which is a serum marker with high sensitivity and specificity for cardiac myocyte injury, could aid in the diagnosis of myocarditis. Methods and Results: To validate this approach, cTnI values were first measured in mice with autoimmune myocarditis. cTnI values were elevated in 24 of 26 mice with myocarditis but were not elevated in any of the control animals (P<.001). Next, cTnI values were measured in the sera from 88 patients referred to the Myocarditis Treatment Trial were compared with creatine kinase-MB (CK-MB) values measured in the same patients. cTnI values were elevated in 18 (34%) of 53 patients with myocarditis and in only 4 (11%) of 35 patients without myocarditis (P=.01). In contrast, CK-MB values were elevated in only 3 (5.7%) of 53 patients with myocarditis and 0 of 35 patients without myocarditis (P=.27). Thus, elevations of cTnI occurred more frequently than did elevations of CK-MB in patients with biopsy-proven myocarditis (P=.001). Importantly, elevations of cTnI in patients with myocarditis were significantly correlated with ≤1 month duration of heart failure symptoms (P=.02), suggesting that the majority of myocyte necrosis occurs early, and thus the window for diagnosis and treatment may be relatively brief. Conclusions: cTnI was superior to CK-MB for detection of myocyte injury in myocarditis, and cTnI elevations were substantially more commons in the first month after the onset of heart failure symptoms.

KW - cardiac troponin I

KW - creatine kinase

KW - diagnosis

KW - myocarditis

UR - http://www.scopus.com/inward/record.url?scp=0031025578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031025578&partnerID=8YFLogxK

M3 - Article

C2 - 8994432

AN - SCOPUS:0031025578

VL - 95

SP - 163

EP - 168

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 1

ER -